APO Research
Talk to an analyst

APO RESEARCH · REPORT

Angiopoietin 1 Receptor

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Angiopoietin 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025184 pages

Choose your research edition.

Industry ResearchAngiopoietin 1 Receptor Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Angiopoietin 1 Receptor Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Angiopoietin 1 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Angiopoietin 1 Receptor Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Angiopoietin 1 Receptor Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Angiopoietin 1 Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Angiopoietin 1 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Angiopoietin 1 Receptor include Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., PharmAbcine, Inc., Exelixis, Inc., Eddingpharm, Deciphera Pharmaceuticals, LLC and Aerpio Therapeutics, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Angiopoietin 1 Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Angiopoietin 1 Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Angiopoietin 1 Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Angiopoietin 1 Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.

Angiopoietin 1 Receptor Segment by Company

Teva Pharmaceutical Industries Ltd.

Sanofi

Pfizer Inc.

PharmAbcine, Inc.

Exelixis, Inc.

Eddingpharm

Deciphera Pharmaceuticals, LLC

Aerpio Therapeutics, Inc.

Angiopoietin 1 Receptor Segment by Type

AP-185

ARP-1536

MAN-01

PMC-001

Others

Angiopoietin 1 Receptor Segment by Application

Ureter Cancer

Neuroendocrine Tumors

Ovarian Cancer

Bladder Cancer

Others

Angiopoietin 1 Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiopoietin 1 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiopoietin 1 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiopoietin 1 Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Angiopoietin 1 Receptor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Angiopoietin 1 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Angiopoietin 1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Angiopoietin 1 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Angiopoietin 1 Receptor Industry Trends Table 2. Angiopoietin 1 Receptor Industry Drivers Table 3. Angiopoietin 1 Receptor Industry Opportunities and Challenges Table 4. Angiopoietin 1 Receptor Industry Restraints Table 5. Global Angiopoietin 1 Receptor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Angiopoietin 1 Receptor Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Angiopoietin 1 Receptor Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Angiopoietin 1 Receptor Sales Market Share by Manufacturers Table 9. Global Angiopoietin 1 Receptor Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Angiopoietin 1 Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Angiopoietin 1 Receptor Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Angiopoietin 1 Receptor Manufacturers, Product Type & Application Table 13. Global Angiopoietin 1 Receptor Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Angiopoietin 1 Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of AP-185 Table 17. Major Manufacturers of ARP-1536 Table 18. Major Manufacturers of MAN-01 Table 19. Major Manufacturers of PMC-001 Table 20. Major Manufacturers of Others Table 21. Global Angiopoietin 1 Receptor Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Angiopoietin 1 Receptor Sales by Type (2021-2026) & (W Units) Table 23. Global Angiopoietin 1 Receptor Sales by Type (2027-2032) & (W Units) Table 24. Global Angiopoietin 1 Receptor Sales Market Share by Type (2021-2026) Table 25. Global Angiopoietin 1 Receptor Sales Market Share by Type (2027-2032) Table 26. Global Angiopoietin 1 Receptor Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 27. Global Angiopoietin 1 Receptor Revenue by Type (2021-2026) & (W Units) Table 28. Global Angiopoietin 1 Receptor Revenue by Type (2027-2032) & (W Units) Table 29. Global Angiopoietin 1 Receptor Revenue Market Share by Type (2021-2026) Table 30. Global Angiopoietin 1 Receptor Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Ureter Cancer Table 32. Major Manufacturers of Neuroendocrine Tumors Table 33. Major Manufacturers of Ovarian Cancer Table 34. Major Manufacturers of Bladder Cancer Table 35. Major Manufacturers of Others Table 36. Global Angiopoietin 1 Receptor Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 37. Global Angiopoietin 1 Receptor Sales by Application (2021-2026) & (W Units) Table 38. Global Angiopoietin 1 Receptor Sales by Application (2027-2032) & (W Units) Table 39. Global Angiopoietin 1 Receptor Sales Market Share by Application (2021-2026) Table 40. Global Angiopoietin 1 Receptor Sales Market Share by Application (2027-2032) Table 41. Global Angiopoietin 1 Receptor Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 42. Global Angiopoietin 1 Receptor Revenue by Application (2021-2026) & (W Units) Table 43. Global Angiopoietin 1 Receptor Revenue by Application (2027-2032) & (W Units) Table 44. Global Angiopoietin 1 Receptor Revenue Market Share by Application (2021-2026) Table 45. Global Angiopoietin 1 Receptor Revenue Market Share by Application (2027-2032) Table 46. Global Angiopoietin 1 Receptor Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 47. Global Angiopoietin 1 Receptor Sales by Region (2021-2026) & (W Units) Table 48. Global Angiopoietin 1 Receptor Sales Market Share by Region (2021-2026) Table 49. Global Angiopoietin 1 Receptor Sales Forecasted by Region (2027-2032) & (W Units) Table 50. Global Angiopoietin 1 Receptor Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 52. North America Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 53. North America Angiopoietin 1 Receptor Sales by Country (2027-2032) & (W Units) Table 54. Europe Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Europe Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 56. Europe Angiopoietin 1 Receptor Sales by Country (2027-2032) & (W Units) Table 57. Asia Pacific Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 58. Asia Pacific Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 59. Asia Pacific Angiopoietin 1 Receptor Sales by Country (2027-2032) & (W Units) Table 60. South America, Middle East and Africa Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 61. South America, Middle East and Africa Angiopoietin 1 Receptor Sales by Country (2021-2026) & (W Units) Table 62. South America, Middle East and Africa Angiopoietin 1 Receptor Sales by Country (2027-2032) & (W Units) Table 63. Global Angiopoietin 1 Receptor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Angiopoietin 1 Receptor Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Angiopoietin 1 Receptor Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Angiopoietin 1 Receptor Revenue Market Share by Region (2021-2026) Table 67. Global Angiopoietin 1 Receptor Revenue Market Share by Region (2027-2032) Table 68. Teva Pharmaceutical Industries Ltd. Company Information Table 69. Teva Pharmaceutical Industries Ltd. Business Overview Table 70. Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Product Portfolio Table 72. Teva Pharmaceutical Industries Ltd. Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Angiopoietin 1 Receptor Product Portfolio Table 77. Sanofi Recent Development Table 78. Pfizer Inc. Company Information Table 79. Pfizer Inc. Business Overview Table 80. Pfizer Inc. Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Inc. Angiopoietin 1 Receptor Product Portfolio Table 82. Pfizer Inc. Recent Development Table 83. PharmAbcine, Inc. Company Information Table 84. PharmAbcine, Inc. Business Overview Table 85. PharmAbcine, Inc. Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. PharmAbcine, Inc. Angiopoietin 1 Receptor Product Portfolio Table 87. PharmAbcine, Inc. Recent Development Table 88. Exelixis, Inc. Company Information Table 89. Exelixis, Inc. Business Overview Table 90. Exelixis, Inc. Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Exelixis, Inc. Angiopoietin 1 Receptor Product Portfolio Table 92. Exelixis, Inc. Recent Development Table 93. Eddingpharm Company Information Table 94. Eddingpharm Business Overview Table 95. Eddingpharm Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Eddingpharm Angiopoietin 1 Receptor Product Portfolio Table 97. Eddingpharm Recent Development Table 98. Deciphera Pharmaceuticals, LLC Company Information Table 99. Deciphera Pharmaceuticals, LLC Business Overview Table 100. Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product Portfolio Table 102. Deciphera Pharmaceuticals, LLC Recent Development Table 103. Aerpio Therapeutics, Inc. Company Information Table 104. Aerpio Therapeutics, Inc. Business Overview Table 105. Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Product Portfolio Table 107. Aerpio Therapeutics, Inc. Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Angiopoietin 1 Receptor Distributors List Table 111. Angiopoietin 1 Receptor Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Angiopoietin 1 Receptor Product Image Figure 2. Global Angiopoietin 1 Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiopoietin 1 Receptor Market Size (2021-2032) & (US$ Million) Figure 4. Global Angiopoietin 1 Receptor Sales (2021-2032) & (W Units) Figure 5. Global Angiopoietin 1 Receptor Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Angiopoietin 1 Receptor Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. AP-185 Image Figure 9. ARP-1536 Image Figure 10. MAN-01 Image Figure 11. PMC-001 Image Figure 12. Others Image Figure 13. Global Angiopoietin 1 Receptor Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Angiopoietin 1 Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Angiopoietin 1 Receptor Sales Market Share by Type (2021-2032) Figure 16. Global Angiopoietin 1 Receptor Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 17. Global Angiopoietin 1 Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Angiopoietin 1 Receptor Revenue Market Share by Type (2021-2032) Figure 19. Ureter Cancer Image Figure 20. Neuroendocrine Tumors Image Figure 21. Ovarian Cancer Image Figure 22. Bladder Cancer Image Figure 23. Others Image Figure 24. Global Angiopoietin 1 Receptor Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 25. Global Angiopoietin 1 Receptor Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Angiopoietin 1 Receptor Sales Market Share by Application (2021-2032) Figure 27. Global Angiopoietin 1 Receptor Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 28. Global Angiopoietin 1 Receptor Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Angiopoietin 1 Receptor Revenue Market Share by Application (2021-2032) Figure 30. North America Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 31. North America Angiopoietin 1 Receptor Sales Market Share by Country (2021-2032) Figure 32. U.S. Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 33. Canada Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 34. Mexico Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 35. Europe Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Europe Angiopoietin 1 Receptor Sales Market Share by Country (2021-2032) Figure 37. Germany Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 38. France Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 39. U.K. Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 40. Italy Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Netherlands Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 42. Asia Pacific Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Asia Pacific Angiopoietin 1 Receptor Sales Market Share by Country (2021-2032) Figure 44. China Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Japan Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South Korea Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 47. Southeast Asia Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 48. India Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 49. Australia Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 50. South America, Middle East and Africa Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 51. South America, Middle East and Africa Angiopoietin 1 Receptor Sales Market Share by Country (2021-2032) Figure 52. Brazil Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 53. South Africa Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Saudi Arabia Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Turkey Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Argentina Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 57. UAE Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 58. Egypt Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 59. Chile Angiopoietin 1 Receptor Sales and Growth Rate (2021-2032) & (W Units) Figure 60. Global Angiopoietin 1 Receptor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Angiopoietin 1 Receptor Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Angiopoietin 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 63. North America Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Angiopoietin 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 65. Europe Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Angiopoietin 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Angiopoietin 1 Receptor Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Angiopoietin 1 Receptor Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Angiopoietin 1 Receptor Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • AP-185
  • ARP-1536
  • MAN-01
  • PMC-001
  • Others
Applications
  • Ureter Cancer
  • Neuroendocrine Tumors
  • Ovarian Cancer
  • Bladder Cancer
  • Others
Companies covered
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Pfizer Inc.
  • PharmAbcine, Inc.
  • Exelixis, Inc.
  • Eddingpharm
  • Deciphera Pharmaceuticals, LLC
  • Aerpio Therapeutics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Angiopoietin 1 Receptor Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Angiopoietin 1 Receptor Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Angiopoietin 1 Receptor Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Angiopoietin 1 Receptor Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Angiopoietin 1 Receptor Market Dynamics
  1. 2.1 Angiopoietin 1 Receptor Industry Trends
  2. 2.2 Angiopoietin 1 Receptor Industry Drivers
  3. 2.3 Angiopoietin 1 Receptor Industry Opportunities and Challenges
  4. 2.4 Angiopoietin 1 Receptor Industry Restraints
3 Angiopoietin 1 Receptor Market by Manufacturers
  1. 3.1 Global Angiopoietin 1 Receptor Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Angiopoietin 1 Receptor Sales by Manufacturers (2021-2026)
  3. 3.3 Global Angiopoietin 1 Receptor Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Angiopoietin 1 Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Angiopoietin 1 Receptor Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Angiopoietin 1 Receptor Manufacturers, Product Type & Application
  7. 3.7 Global Angiopoietin 1 Receptor Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Angiopoietin 1 Receptor Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Angiopoietin 1 Receptor Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Angiopoietin 1 Receptor Tier 1, Tier 2, and Tier 3
4 Angiopoietin 1 Receptor Market by Type
  1. 4.1 Angiopoietin 1 Receptor Type Introduction
  2. 4.1.1 AP-185
  3. 4.1.2 ARP-1536
  4. 4.1.3 MAN-01
  5. 4.1.4 PMC-001
  6. 4.1.5 Others
  7. 4.2 Global Angiopoietin 1 Receptor Sales by Type
  8. 4.2.1 Global Angiopoietin 1 Receptor Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Angiopoietin 1 Receptor Sales by Type (2021-2032)
  10. 4.2.3 Global Angiopoietin 1 Receptor Sales Market Share by Type (2021-2032)
  11. 4.3 Global Angiopoietin 1 Receptor Revenue by Type
  12. 4.3.1 Global Angiopoietin 1 Receptor Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Angiopoietin 1 Receptor Revenue by Type (2021-2032)
  14. 4.3.3 Global Angiopoietin 1 Receptor Revenue Market Share by Type (2021-2032)
5 Angiopoietin 1 Receptor Market by Application
  1. 5.1 Angiopoietin 1 Receptor Application Introduction
  2. 5.1.1 Ureter Cancer
  3. 5.1.2 Neuroendocrine Tumors
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Bladder Cancer
  6. 5.1.5 Others
  7. 5.2 Global Angiopoietin 1 Receptor Sales by Application
  8. 5.2.1 Global Angiopoietin 1 Receptor Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Angiopoietin 1 Receptor Sales by Application (2021-2032)
  10. 5.2.3 Global Angiopoietin 1 Receptor Sales Market Share by Application (2021-2032)
  11. 5.3 Global Angiopoietin 1 Receptor Revenue by Application
  12. 5.3.1 Global Angiopoietin 1 Receptor Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Angiopoietin 1 Receptor Revenue by Application (2021-2032)
  14. 5.3.3 Global Angiopoietin 1 Receptor Revenue Market Share by Application (2021-2032)
6 Global Angiopoietin 1 Receptor Sales by Region
  1. 6.1 Global Angiopoietin 1 Receptor Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Angiopoietin 1 Receptor Sales by Region (2021-2032)
  3. 6.2.1 Global Angiopoietin 1 Receptor Sales by Region (2021-2026)
  4. 6.2.2 Global Angiopoietin 1 Receptor Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Angiopoietin 1 Receptor Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Angiopoietin 1 Receptor Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Angiopoietin 1 Receptor Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Angiopoietin 1 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Angiopoietin 1 Receptor Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Angiopoietin 1 Receptor Revenue by Region
  1. 7.1 Global Angiopoietin 1 Receptor Revenue by Region
  2. 7.1.1 Global Angiopoietin 1 Receptor Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Angiopoietin 1 Receptor Revenue by Region (2021-2026)
  4. 7.1.3 Global Angiopoietin 1 Receptor Revenue by Region (2027-2032)
  5. 7.1.4 Global Angiopoietin 1 Receptor Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Angiopoietin 1 Receptor Revenue (2021-2032)
  8. 7.2.2 North America Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Angiopoietin 1 Receptor Revenue (2021-2032)
  11. 7.3.2 Europe Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Angiopoietin 1 Receptor Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Angiopoietin 1 Receptor Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Angiopoietin 1 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries Ltd.
  2. 8.1.1 Teva Pharmaceutical Industries Ltd. Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Ltd. Angiopoietin 1 Receptor Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Angiopoietin 1 Receptor Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Pfizer Inc.
  14. 8.3.1 Pfizer Inc. Company Information
  15. 8.3.2 Pfizer Inc. Business Overview
  16. 8.3.3 Pfizer Inc. Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Inc. Angiopoietin 1 Receptor Product Portfolio
  18. 8.3.5 Pfizer Inc. Recent Developments
  19. 8.4 PharmAbcine, Inc.
  20. 8.4.1 PharmAbcine, Inc. Company Information
  21. 8.4.2 PharmAbcine, Inc. Business Overview
  22. 8.4.3 PharmAbcine, Inc. Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PharmAbcine, Inc. Angiopoietin 1 Receptor Product Portfolio
  24. 8.4.5 PharmAbcine, Inc. Recent Developments
  25. 8.5 Exelixis, Inc.
  26. 8.5.1 Exelixis, Inc. Company Information
  27. 8.5.2 Exelixis, Inc. Business Overview
  28. 8.5.3 Exelixis, Inc. Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Exelixis, Inc. Angiopoietin 1 Receptor Product Portfolio
  30. 8.5.5 Exelixis, Inc. Recent Developments
  31. 8.6 Eddingpharm
  32. 8.6.1 Eddingpharm Company Information
  33. 8.6.2 Eddingpharm Business Overview
  34. 8.6.3 Eddingpharm Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eddingpharm Angiopoietin 1 Receptor Product Portfolio
  36. 8.6.5 Eddingpharm Recent Developments
  37. 8.7 Deciphera Pharmaceuticals, LLC
  38. 8.7.1 Deciphera Pharmaceuticals, LLC Company Information
  39. 8.7.2 Deciphera Pharmaceuticals, LLC Business Overview
  40. 8.7.3 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Deciphera Pharmaceuticals, LLC Angiopoietin 1 Receptor Product Portfolio
  42. 8.7.5 Deciphera Pharmaceuticals, LLC Recent Developments
  43. 8.8 Aerpio Therapeutics, Inc.
  44. 8.8.1 Aerpio Therapeutics, Inc. Company Information
  45. 8.8.2 Aerpio Therapeutics, Inc. Business Overview
  46. 8.8.3 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aerpio Therapeutics, Inc. Angiopoietin 1 Receptor Product Portfolio
  48. 8.8.5 Aerpio Therapeutics, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Angiopoietin 1 Receptor Value Chain Analysis
  2. 9.1.1 Angiopoietin 1 Receptor Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Angiopoietin 1 Receptor Production Mode & Process
  6. 9.2 Angiopoietin 1 Receptor Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Angiopoietin 1 Receptor Distributors
  9. 9.2.3 Angiopoietin 1 Receptor Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst